Brazil's new law on preferential treatment for domestic medtech a concern for US and EU industry
This article was originally published in RAJ Devices
The US and EU medtech industries have voiced their concern over a new law implemented by the Brazilian government to boost its country's home-grown medtech businesses1.
You may also be interested in...
France has announced a number of emergency measures to protect drug supplies threatened by the spread of the coronavirus.
Major generics companies have donated hydroxychloroquine sulfate doses for research and treatment of coronavirus. Companies are also donating hand sanitizer and personal protective equipment and are preparing to ramp up manufacturing and production.
Inovio forges ahead into Phase I trials with DNA-based vaccine candidate, but can it prove skeptics wrong?